Second Malignancies in High‑Dose Areas of Previous Tumor RadiotherapyB. Welte, Thomas Wiegel, P. Suhr et al.|Strahlentherapie und Onkologie|2010Cited by 39
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical ProstatectomyAlberto Martini, Alberto Briganti, Luca Boeri et al.|European Urology Oncology|2019Cited by 4